Q4FY17 Results: Thyrocare Technologies Ltd
Amir Shaikh / 10 May 2017
Thyrocare Technologies Ltd. reported its results for the quarter ended March 31, 2017, on Tuesday.
Thyrocare Technologies Ltd. reported its results for the quarter ended March 31, 2017, on Tuesday.
Total sales for this quarter, Q4FY17, came in at Rs. 87.67 crores. This represents a 23.37 per cent sequential increase and 34.77 per cent YoY increase.
Operating profit (EBIT) for the recently concluded quarter amounted to Rs. 28.25 crore and the EBIT margin stood at 32.22 per cent.
The reported PAT of Rs. 18.95 crore which represents a sequential QoQ increase of 23.29 per cent and a YoY increase of 36.04 per cent.
The Board of Directors has approved a final dividend of Rs. 5 per equity share for the face value of Rs. 10 each.
In today’s trading session, it had kicked off the day at Rs. 760, almost up by 5.7% from its last closing on BSE. At 10:14 a.m., it was trading at Rs. 738.2 on BSE.
Thyrocare Technologies Limited is an India-based healthcare service provider. The Company operates with a centralised processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.